Page 56 - Aneesh Phadnis

Regulatory issues keep Sun Pharma stock under cloud

Stock is 40% below its all-time high touched last year

Newsmaker: Dilip Shanghvi

With bids for seven blocks, Shanghvi wants to secure a big slice of the oil and gas business

Sun Pharma's sharpens emerging market focus with $60 mn acquisition in Russia

Sun Pharma will pay $24 mn for 85% equity and will assume $36 mn debt as part of the transaction

Make plant inspection reports public, Indian Pharmaceutical Alliance tells government

Recommendation comes in the backdrop of inspections at 76 manufacturing units carried out by CDSCO and state drug regulators

MakeMyTrip gets the show on the road

The online travel portal moves beyond discounts as it looks to extend its brand into niche and value-added services

Govt's equity flow choke might block Air India revival path

Air India received Rs 1,713 crore of equity in the Budget, against its requirement of Rs 3,900 crore

Demonetisation: Govt's move to delay holiday bookings

Consumers have put off discretionary spending for now, say travel agencies

Cipla plans to get more aggressive in US, UK

The market size for blockbuster inhaler Seretide in Britain was $400 million last year, say analysts

Demonetisation to delay bookings, bring changes in customer behaviour: Thomas Cook India MD

However, the company has seen an uptick in online bookings following demonetisation decision

Funding in AirAsia takes a hit as promoters cut investment

Tata Sons along with Malaysia-based AirAsia Bhd are the promoters of the airline

Demonetisation: Tourism sector may face the heat this winter

The online travel industry is bullish about the growth prospects after the demonetisation is settled

Tourism sector feels winter chill

An immediate impact is being felt across the industry in new bookings while foreign tourists are troubled due to inadequate availability of local currency

Low fares, high costs are a challenge in India, says Lufthansa's India head Wolfgang Will

Will said Indian market is so competitive that airlines are struggling to get decent average revenue per passenger

Jet Airways sells 3 A330 planes, posts modest profit of Rs 85 crore

The airline has made a provision of Rs 129 crore for potential loss from sale

No refund on cash bookings with old notes at airports till Friday, PAN mandatory

The government now fears black money holders will use airline counters as a loophole to transact in cash

Sun Pharma profit doubles on sales growth, licensing income

Net profit rises to Rs 2,235 crore in Q2 FY 17 as against Rs 1,028 crore in same period last year

India readies to do business with Trump

Congruence on terrorism, current disquiet on immigration, short-term visa would top the wish list

FMCG firms brace for retailer backlash

E-commerce majors & airline operators rejoice

Sweet pill for Indian pharma as Donald 'Trumps' Clinton

As a part of his seven-point health care agenda, Trump had said this would allow consumers access to better drugs made abroad

Trump win might mean opportunities for Indian pharma

Trump had proposed to lift entry barriers for drug makers that offer safe, reliable and cheaper products